Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.1 (
hexokinase
)
5,274
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rabbit myeloid myelocaryocytes possessed higher activities of
hexokinase
(HK) and lactate dehydrogenase (LDH) as compared with those of erythroid cells. The lypolytic activity was twice as high in myeloid myelocaryocytes as in erythroid ones. Both strains of medullar cells did not differ in the activity of
glucose-6-phosphate dehydrogenase
(
G6PD
). But the isoenzyme spectra of
G6PD
varied distinctly in these cells; HK and LDH isoenzyme spectra were the same both in myeloid and erythroid cells. The enzymatic activity was altered dissimilarly in myeloid and erythroid cells after administration of hydrocortisone. In myeloid cells the HK activity was decreased, in the erythroid cells--the HK activity tended to increase and the lipolytic activity was decreased. Alterations in the isoenzyme spectra of
G6PD
and LDH, caused by hydrocortisone administration, exhibited similar patterns in myeloid and erythroid cells.
...
PMID:[Isoenzyme spectrum and activity of several enzymes of bone marrow erythroid and myeloid cells in rabbits and changes in them under the influence of hydrocortisone]. 68 90
A new method of measuring glucose concentrations (Reflotest-Hypoglycemie) was tested on 141 serum samples and 119 capillary blood samples and compared with the
hexokinase
-
glucose-6-phosphate dehydrogenase
method. The Reflotest (reflectance meter) compared well with the reference test. Comparison of results with three sera measured by the method in six different laboratories indicated the accuracy of the test. Endogenous bilirubin, uric acid, and haematocrit values did not influence the result. The test is therefore suitable for quantitative measurements.
...
PMID:[A simple and quick method for measuring low blood-glucose concentrations (author's transl)]. 71 Mar 5
Despite the presence of a marked decrease in liver protein content 48 h after a single injection of D-galactosamine, increased activities of
glucose-6-phosphate dehydrogenase
, low-Km
hexokinase
and pyruvate kinase type M2 were observed in the injured liver. Microsomal aniline hydroxylase activity and cytochrome P-450 content in liver decreased significantly in 48 h of galactosamine treatment but not in the first 2 h in contrast with carbon tetrachloride (CCL4) intoxication. The extents of those changes were not so great as in CCl4-treated rats. The disaggreation of polyribosomes in liver was observed in 24 h of galactosamine treatment. However, the formation of microsomal lipoperoxidation did not increase in the entire course of acute liver injury by the amino sugar. These results taken together with our previous observations indicate that the dysregulation of protein synthesis is an essential biochemical event of hepatocyte injury induced by treatment of rats with galactosamine as well as CCl4.
...
PMID:Dysregulation of protein synthesis in injured liver. A comparative study on microsomal and cytosole enzyme activities, microsomal lipoperoxidation and polysomal pattern in D-galactosamine and carbon tetrachloride-injured livers. 71 Mar 83
The D-glucose anomeric preference of hexokinases isolated from rat liver, brain, and skeletal muscle, and bovine retina was studied using the
glucose-6-phosphate dehydrogenase
-NADP system. The ratios of maximum phosphorylation rates of beta-D-glucose to those of alpha-D-glucose were 1.33, 1.46, and 1.54 for
hexokinase
types I, II, and III from rat liver, 1.45 and 1.63 for type I from rat brain and bovine retina, 1.53 for type II from rat skeletal muscle, and 0.55 (when determined at 5 mM) for type IV (glucokinase) from rat liver, respectively.
...
PMID:D-Glucose anomeric preference of hexokinases in higher animals. 71 11
The ratios of some key enzymatic activities of carbohydrate metabolism have been measured in human tumor cytosols. The activities of whole
hexokinase
(low Km,
EC 2.7.1.1
and high Km, EC 2.7.1.2), 6-phosphogluconate dehydrogenase (EC 1.1.1.43),
glucose-6-phosphate dehydrogenase
(
EC 1.1.1.49
) and glucose-6-phosphate isomerase (EC 5.3.1.9) change according to a biochemical pattern coherent with cell growth requirements. 6-phosphogluconate dehydrogenase activity was in each sample tested higher than
glucose-6-phosphate dehydrogenase
activity; this indicates that 6-phosphogluconate, a powerful inhibitor of glucose-6-phosphate isomerase, is unlikely to accumulate and inhibit this enzyme and glucose-6-phosphate channelling into glycolysis.
...
PMID:6-phosphogluconate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphate isomerase, and hexokinase activity ratios in some human tumor cytosols. 74 21
Detailed histochemical studies have been conducted on the distribution of
hexokinase
, amylophosphorylase, aldolase, lactic dehydrogenase, succinic dehydrogenase and
glucose-6-phosphate dehydrogenase
in every component of the locus ceruleus, nucleus tractus mesencephalicus n. trigemini, nucleus dorsalis n. vagi and nucleus n. hypoglossi of the wistar strain rats. The locus ceruleus and nucleus dorsalis n. vagi which are considered to be belong to "exceptional nuclei" showed mild activity in the nerve cell bodies and strong activity in the surrounding glia cell for the
hexokinase
reaction. But, the nucleus tractus mesencephalicus n. trigemini and nucleus n. hypoglossi considered to be "usual nuclei" revealed strong activity in the nerve cell bodies and glia cells for the
hexokinase
reaction, however, glia cells did not show the tendency to surround the nerve cells in these nuclei. On the basis of the present findings, the glia cells may get their energy source from glucose in the circulating blood, and they may be energy donators to the nerve cells in the "exceptional nuclei" whereas the nerve cells may get their energy source directly from glucose in the circulating blood in the "usual nuclei". The former 2 nuclei showed low level activity of succinic dehydrogenase. These findings may indicate that the locus ceruleus and nucleus dorsalis n. vagi belong to the conception "exceptional nuclei" in this respect. However, the Embden-Meyerhof-Parnas (EMP) pathway was dominant in the locus ceruleus, while the WARBURG-DICKENS pathway (hexose monophosphate shunt = HMP shunt) was dominant in the nucleus dorsalis n. vagi in the present study. This descrepancy may strongly suggest that the locus ceruleus is distinctly different from the nucleus dorsalis n. vagi concerning the carbohydrate metabolism, though both nuclei are involved on the same conception "exceptional nuclei". The latter 2 nuclei (the nucleus tractus mesencephalicus n. trigemini and the nucleus n. hypoglossi) considered to be "usual nuclei" in 3 ways as that nerve cells get energy source directly from glucose in the circulating blood, that the 2 nuclei are equipped with enzymes involved in the EMP pathway and the HMP shunt to the same degree, and that they are rich in the tricarboxylic acid (TCA) cycle. The nucleus tractus mesencephalicus n. trigemini revealed considerably variable reactions for the
hexokinase
, aldolase,
glucose-6-phosphate dehydrogenase
and lactic dehydrogenase in the present study.
...
PMID:Histochemical studies on the distribution of some enzymes concerned with carbohydrate metabolism in the locus ceruleus, nucleus tractus mesencephalicus n. trigemini, nucleus dorsalis n. vagi and nucleus n. hypoglossi of the rat. 80 76
Haemoglobin fractions and 16 enzymatic activities of red cells of a patient with juvenile chronic myeloid leukaemia are compared to normal, to comparably reticulocyte-rich, non-neonatal and to fetal red cells. The activities of
hexokinase
, triosephosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, monophosphoglyceromutase, enolase and
glucose-6-phosphate dehydrogenase
are significantly increased in fetal red cells beyond the activities of cell populations with comparable reticulocytosis. The activities of these enzymes are also increased in the patient's erythrocytes. Together with a haemoglobin F concentration of 54% and a concentration of haemoglobin Bart's of 1% these variations reflect the fetal nature of the red cells. Simultaneously, signs of dyserythropoiesis are found in the red cells of the patient: a very high activity of
hexokinase
and a low pyruvate kinase activity.
...
PMID:Fetal erythropoiesis and dyserythropoiesis in juvenile chronic myeloid leukaemia. 82 74
Glucose turnover was measured in normal and disbetic dogs by the dilution of glucose-1-13C and glucose-1-14C tracers infused simultaneously at constant rates. In order to quantify the stable isotope, an enzymatic assay for the analysis of glucose-1-13C was developed and evaluated. CO2 from C-1 glucose was evolved by coupling
hexokinase
,
glucose-6-phosphate dehydrogenase
, and 6-phosphogluconic dehydrogenase activities. The 13C/12C ratio of the CO2 was measured with a high-precision magnetic-deflection double-collector mass spectrometer, and the radioactivity of 14CO2 was quantified by liquid scintillation. The ratio of 13C/12C was reproducible in assays of CO2 evolved from either naturally occurring or 13C-enriched glucose. Furthermore, systemic glucose production rates measured with 13C- and 14C-labeled tracers were similar over a wide range from 2 to 12 mg./kg.-min. Thus, glucose-1-13C may be employed as a tracer for glucose metabolism in human subjects without incurring the risk of radiation.
...
PMID:Estimation of glucose turnover with stable tracer glucose-1-13C. 83 67
The compounds P1-(adenosine-5')-P3-(glucose-6) triphosphate (Ap3 glucose) and P1-(adenosine-5')-P4-(glucose-6)tetraphosphate (Ap4 glucose) were synthesized as possible transition-state analogs for
hexokinase
(ATP: D-hexose 6- phosphotransferase,
EC 2.7.1.1
). Both compounds were inhibitors of this enzyme, competitive against ATP and apparently uncompetitive against glucose. The inhibition constants for Ap3 glucose and Ap4 glucose were 0.43 mM and 0.37 mM, respectively. These results indicate that the inhibitors do not appreciably bind to
hexokinase
until the glucose binding site is filled. The sugar portion of the inhibitors therefore does not contribute to binding, and the compounds are acting as ATP analogs, Ap3 glucose and Ap4 glucose are also slow substrates for
glucose-6-phosphate dehydrogenase
.
...
PMID:Inhibition of hexokinase by multisubstrate analogs. 83 47
The activity of glutathione peroxidase (GSH Px),
glucose-6-phosphate dehydrogenase
(G-6-PD),
hexokinase
, and glutamic oxaloacetic transaminase (EGOT) was measured in 78 blood samples. GSH Px activity was not found to correlate with
hexokinase
or EGOT activity, indicating that it was not a strongly age-dependent enzyme. Although modest elevations of GSH Px activity were observed in the red cells of patients with a variety of hematologic disorders, the most consistent and striking increases in activity were observed in G-6-PD-deficient subjects.
...
PMID:Glucose-6-phosphate dehydrogenase deficiency and red cell glutathione peroxidase. 83 54
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>